← Leaderboards
T. Celeste Napier
Loyola University Chicago
$4,136,781
Attributed
$4,989,283
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $434.5K · FY2005–22$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,989,283 · 8
By mechanism
R21$2,557,504 · 6
R01$2,431,779 · 2
Top collaborators
- Amanda Lee Mickiewicz4 shared
- Xiu-Ti Hu2 shared
- Alana E. Kirby1 shared
Most similar at Loyola University Chicago
Same institution · by research overlap
- Amanda Lee Mickiewicz$502,451
Others in their field
Top investigators on “Dopamine”
- Pedro A. Jose · George Washington University$34,248,029
- Jonathan A Javitch · Columbia University Health Sciences$28,566,988
- Michael A Nader · Emory University$26,344,520
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,527,588
- Michael A Schwarzschild · Massachusetts General Hospital$22,973,787
- David Sulzer · Columbia University Health Sciences$22,837,505
Research focus
DopamineLaboratory RatRattusExhibitsDrug AddictionNucleus AccumbensNeuronsMediatingProtocols DocumentationBrainMotorInnovationPharmaceutical PreparationsFutureMethamphetamineMolecularBehaviorDoseNeuropathologyNeuropharmacologyAnimalsLinkDrug WithdrawalBrain Region
Grant awards (22)
Limbic pallidal circuits linked to apathy in Parkinsonâs disease during subthalamic deep brain stimulation$434,500
R21 · FY2022 · NS
Cocaine Abuse and HIV Comorbidity: Relapse-Related Brain Pathology.$196,250
R21 · FY2020 · DA · contact PI
Cocaine Abuse and HIV Comorbidity: Relapse-Related Brain Pathology.$235,500
R21 · FY2019 · DA · contact PI
A novel 'dual hit' model of environmental risk factors for Parkinson's Disease$193,750
R21 · FY2016 · ES · contact PI
A novel 'dual hit' model of environmental risk factors for Parkinson's Disease$232,500
R21 · FY2015 · ES · contact PI
Brain signaling effects of pramipexole-induced impulsivity in parkinsonian rats$191,250
R21 · FY2015 · NS · contact PI
Brain signaling effects of pramipexole-induced impulsivity in parkinsonian rats$241,434
R21 · FY2014 · NS · contact PI
Cortical pathophysiology in cocaine sef-administering HIV-1 transgenic rats$220,320
R21 · FY2013 · DA
A novel rodent model of dopamine agonist-induced impulsive control disorders$229,500
R21 · FY2012 · NS · contact PI
Cortical pathophysiology in cocaine sef-administering HIV-1 transgenic rats$191,250
R21 · FY2012 · DA
A novel rodent model of dopamine agonist-induced impulsive control disorders$191,250
R21 · FY2011 · NS · contact PI
5-HT & Medication Development for Methamphetamine Abuse$331,352
R01 · FY2007 · DA · contact PI
5-HT & Medication Development for Methamphetamine Abuse$250,632
R01 · FY2006 · DA · contact PI
5-HT & Medication Development for Methamphetamine Abuse$91,752
R01 · FY2006 · DA · contact PI
5-HT &Medication Development for Methamphetamine Abuse$351,720
R01 · FY2005 · DA
5-HT &Medication Development for Methamphetamine Abuse$348,435
R01 · FY2004 · DA
OPIOIDS AND THE PHYSIOLOGY OF THE VENTRAL PALLIDUM$175,312
R01 · FY2004 · DA
5-HT &Medication Development for Methamphetamine Abuse$341,891
R01 · FY2003 · DA
OPIOIDS AND THE PHYSIOLOGY OF THE VENTRAL PALLIDUM$170,208
R01 · FY2003 · DA
OPIOIDS AND THE PHYSIOLOGY OF THE VENTRAL PALLIDUM$165,250
R01 · FY2002 · DA
OPIOIDS AND THE PHYSIOLOGY OF THE VENTRAL PALLIDUM$160,436
R01 · FY2001 · DA
OPIOIDS AND THE PHYSIOLOGY OF THE VENTRAL PALLIDUM$44,791
R01 · FY2000 · DA